Stocks and Investing
Stocks and Investing
Fri, November 4, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Robert Burns Maintained (SWTX) at Strong Buy with Decreased Target to $99 on, Nov 4th, 2022
Robert Burns of HC Wainwright & Co., Maintained "SpringWorks Therapeutics, Inc." (SWTX) at Strong Buy with Decreased Target from $103 to $99 on, Nov 4th, 2022.
Robert has made no other calls on SWTX in the last 4 months.
There is 1 other peer that has a rating on SWTX. Out of the 1 peers that are also analyzing SWTX, 0 agree with Robert's Rating of Hold.
This is the rating of the analyst that currently disagrees with Robert
- Corinne Jenkins of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $44 on, Friday, October 21st, 2022
Contributing Sources